Unleased lab space. Plunging valuations. Layoffs. In Massachusetts, the biotech slump is taking its toll.
There are few signs the industry responsible for more than 115,000 Massachusetts jobs is pulling out of its four-year downswing.
Bioengineered Protein Drugs Market Size To Cross USD 672.7 Billion By 2034, Growing At A CAGR Of 6.2% - Report By Transparency Market Research, Inc.
The bioengineered protein drugs market is experiencing a paradigm shift, with pharmaceutical and biotech companies leveraging advanced biopharmaceuti ...
PMLive19h
Biogen initiates phase 3 study of felzartamab in kidney transplant patients
Beyond AMR, Biogen is planning to initiate phase 3 trials of felzartamab in two kidney diseases, IgA nephropathy and primary ...
STAT19h
In the Boston area, biotech’s hub, a slump is being acutely felt
In the Boston area, three months into the new year, the mood in the biotech industry has soured and the outlook has clouded.
Fierce Biotech16h
Samsung backs Alzheimer's blood test developer C2N Diagnostics with $10M
Samsung is backing Alzheimer’s disease blood test developer C2N Diagnostics, with $10 million to help scale up its commercial ...
Multiple Sclerosis Therapeutics Market Projected To Witness Substantial Growth, 2025-2032: Biogen Inc., Novartis AG
Multiple Sclerosis Therapeutics Size Multiple Sclerosis Therapeutics Market is estimated to be valued at USD 31.39 Bn in 2025 and is expect ...